See more : InterCare DX, Inc. (ICCO) Income Statement Analysis – Financial Results
Complete financial analysis of Thomson Reuters Corporation (TRI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Thomson Reuters Corporation, a leading company in the Specialty Business Services industry within the Industrials sector.
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) Income Statement Analysis – Financial Results
- Kidpik Corp. (PIK) Income Statement Analysis – Financial Results
- Cardinal Health, Inc. (0HTG.L) Income Statement Analysis – Financial Results
- Fire & Flower Holdings Corp. (FFLWF) Income Statement Analysis – Financial Results
- Mahaveer Infoway Limited (MINFY.BO) Income Statement Analysis – Financial Results
Thomson Reuters Corporation (TRI)
About Thomson Reuters Corporation
Thomson Reuters Corporation provides business information services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in five segments: Legal Professionals, Corporates, Tax & Accounting Professionals, Reuters News, and Global Print. The Legal Professionals segment offers research and workflow products focusing on legal research and integrated legal workflow solutions that combine content, tools, and analytics to law firms and governments. The Corporates segment provides a suite of content-enabled technology solutions for legal, tax, regulatory, compliance, and IT professionals. The Tax & Accounting Professionals segment offers research and workflow products focusing on tax offerings and automating tax workflows to tax, accounting, and audit professionals in accounting firms. The Reuters News segment provides business, financial, and international news to media organizations, professional, and news consumers through news agency and industry events. The Global Print segment offers legal and tax information primarily in print format to legal and tax professionals, governments, law schools, and corporations. The company was formerly known as The Thomson Corporation and changed its name to Thomson Reuters Corporation in April 2008. The company was founded in 1851 and is headquartered in Toronto, Canada. Thomson Reuters Corporation is a subsidiary of The Woodbridge Company Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.79B | 6.63B | 6.35B | 5.98B | 5.91B | 5.50B | 11.33B | 11.17B | 12.21B | 12.61B | 12.70B | 13.28B | 13.81B | 13.07B | 13.00B | 11.71B | 7.30B | 6.64B | 8.70B | 8.10B | 7.61B | 7.76B | 7.24B | 6.51B | 5.75B | 6.27B | 8.77B | 7.72B | 7.23B |
Cost of Revenue | 4.10B | 2.41B | 2.48B | 2.27B | 2.43B | 4.13B | 8.08B | 8.23B | 8.81B | 9.21B | 9.55B | 9.76B | 10.00B | 10.06B | 9.88B | 8.70B | 5.28B | 4.70B | 6.31B | 5.85B | 5.54B | 5.70B | 5.45B | 4.88B | 4.25B | 4.71B | 7.14B | 6.39B | 5.96B |
Gross Profit | 2.70B | 4.22B | 3.87B | 3.72B | 3.48B | 1.37B | 3.25B | 2.93B | 3.40B | 3.40B | 3.15B | 3.52B | 3.81B | 3.01B | 3.12B | 3.01B | 2.02B | 1.94B | 2.40B | 2.25B | 2.06B | 2.06B | 1.79B | 1.63B | 1.50B | 1.56B | 1.63B | 1.34B | 1.27B |
Gross Profit Ratio | 39.73% | 63.66% | 60.96% | 62.08% | 58.84% | 24.90% | 28.71% | 26.28% | 27.84% | 26.95% | 24.78% | 26.48% | 27.59% | 23.02% | 24.02% | 25.69% | 27.70% | 29.20% | 27.52% | 27.75% | 27.14% | 26.56% | 24.68% | 25.07% | 26.08% | 24.82% | 18.55% | 17.30% | 17.54% |
Research & Development | 440.00M | 446.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 773.00M | 691.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 237.00M | 1.62B | 1.62B | 4.00B | 4.41B | 4.13B | 8.08B | 8.23B | 8.81B | 9.21B | 9.55B | 9.76B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | -173.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 64.00M | 1.62B | 1.62B | 4.00B | 4.41B | 4.13B | 8.08B | 8.23B | 8.81B | 9.21B | 9.55B | 9.76B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | -137.00M | 3.17B | 3.48B | 56.00M | 294.00M | 5.00M | -183.00M | -20.00M | 7.00M | 91.00M | 14.00M | -36.00M | 1.51B | 1.59B | 1.55B | 1.31B | 724.00M | 681.00M | 931.00M | 906.00M | 873.00M | 830.00M | 920.00M | 842.11M | 695.03M | 644.03M | 667.02M | 553.96M | 477.30M |
Operating Expenses | 367.00M | 4.79B | 5.11B | 4.06B | 4.71B | 4.72B | 9.58B | 9.78B | 10.48B | 10.06B | 11.19B | 10.63B | 1.51B | 11.65B | 1.55B | 1.31B | 724.00M | 681.00M | 931.00M | 906.00M | 873.00M | 830.00M | 920.00M | 842.11M | 695.03M | 644.03M | 667.02M | 553.96M | 477.30M |
Cost & Expenses | 4.46B | 4.79B | 5.11B | 4.06B | 4.71B | 4.72B | 9.58B | 9.78B | 10.48B | 10.06B | 11.19B | 10.63B | 11.50B | 11.65B | 11.42B | 10.01B | 6.00B | 5.38B | 7.24B | 6.76B | 6.42B | 6.53B | 6.37B | 5.72B | 4.95B | 5.36B | 7.81B | 6.94B | 6.44B |
Interest Income | 85.00M | 444.00M | 8.00M | 30.00M | 44.00M | 13.00M | 8.00M | 50.00M | 39.00M | 7.00M | 16.00M | 40.00M | 19.00M | 28.00M | 22.00M | 142.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 237.00M | 196.00M | 196.00M | 195.00M | 163.00M | 260.00M | 362.00M | 403.00M | 416.00M | 442.00M | 460.00M | 390.00M | 396.00M | 383.00M | 410.00M | 389.00M | 46.00M | 19.00M | 243.00M | 63.00M | 168.00M | 423.00M | 0.00 | 209.36M | 263.08M | 329.03M | 265.06M | 108.06M | 0.00 |
Depreciation & Amortization | 725.00M | 695.31M | 763.22M | 833.84M | 733.67M | 587.43M | 626.76M | 1.53B | 1.68B | 1.82B | 1.83B | 1.75B | 1.71B | 1.57B | 1.56B | 1.24B | 724.00M | 681.00M | 931.00M | 939.00M | 911.00M | 876.00M | 1.02B | 842.11M | 695.03M | 644.03M | 667.02M | 553.96M | 477.30M |
EBITDA | 2.95B | 3.01B | 1.99B | 2.76B | 1.91B | 1.35B | 1.50B | 3.00B | 3.15B | 4.29B | 3.31B | 4.37B | 1.02B | 3.04B | 2.75B | 2.72B | 2.02B | 1.93B | 1.82B | 2.24B | 2.08B | 2.01B | 1.89B | 1.63B | 1.50B | 1.40B | 1.41B | 1.34B | 1.24B |
EBITDA Ratio | 43.42% | 45.30% | 31.82% | 45.97% | 31.34% | 25.67% | 26.60% | 26.80% | 28.28% | 33.97% | 25.93% | 33.43% | 29.07% | 22.69% | 19.27% | 23.23% | 28.17% | 29.18% | 27.84% | 27.86% | 26.66% | 27.67% | 22.36% | 25.11% | 27.42% | 25.60% | 18.39% | 15.11% | 12.42% |
Operating Income | 2.33B | 1.83B | 1.24B | 1.93B | 1.20B | 780.00M | 1.76B | 1.39B | 1.73B | 2.55B | 1.52B | 2.65B | -705.00M | 1.42B | 1.58B | 1.69B | 1.30B | 1.26B | 1.46B | 1.34B | 1.19B | 1.22B | 1.79B | 790.77M | 805.07M | 912.01M | 959.08M | 781.98M | 790.61M |
Operating Income Ratio | 34.32% | 27.67% | 19.57% | 32.24% | 20.30% | 14.18% | 15.49% | 12.45% | 14.20% | 20.19% | 11.94% | 19.97% | -5.11% | 10.86% | 12.12% | 14.46% | 17.78% | 18.94% | 16.82% | 16.56% | 15.66% | 15.78% | 24.68% | 12.14% | 14.00% | 14.55% | 10.94% | 10.13% | 10.94% |
Total Other Income/Expenses | 731.00M | -184.00M | -188.00M | -165.00M | -228.00M | -326.00M | -527.00M | -505.00M | -104.00M | -527.00M | -513.00M | -413.00M | -2.94B | -355.00M | -1.04B | -23.00M | -46.00M | -220.00M | 41.00M | -114.62M | -191.00M | -338.00M | -934.00M | -206.69M | -262.67M | -188.06M | -147.04M | -108.06M | 94.98M |
Income Before Tax | 3.06B | 2.08B | 1.05B | 1.76B | 971.00M | 533.00M | 1.19B | 1.04B | 1.36B | 2.02B | 1.00B | 2.30B | -1.12B | 1.06B | 538.00M | 1.76B | 1.25B | 1.04B | 1.21B | 1.13B | 1.00B | 798.00M | 852.00M | 584.08M | 541.99M | 582.98M | 680.03M | 673.91M | 885.59M |
Income Before Tax Ratio | 45.08% | 31.42% | 16.60% | 29.48% | 16.44% | 9.69% | 10.50% | 9.29% | 11.11% | 16.01% | 7.90% | 17.33% | -8.08% | 8.14% | 4.14% | 15.00% | 17.15% | 15.63% | 13.94% | 13.95% | 13.15% | 10.29% | 11.77% | 8.97% | 9.42% | 9.30% | 7.76% | 8.73% | 12.25% |
Income Tax Expense | 417.00M | 195.00M | 1.61B | 71.00M | -1.20B | 141.00M | -274.00M | -15.00M | 56.00M | 62.00M | 848.00M | 157.00M | 293.00M | 139.00M | -299.00M | 351.00M | 155.00M | 119.00M | 287.00M | 267.00M | 156.00M | 192.00M | 168.00M | -14.67M | 105.00M | 108.99M | 101.01M | 92.96M | 86.03M |
Net Income | 2.70B | 1.89B | -553.00M | 1.69B | 2.17B | 3.95B | 1.40B | 3.10B | 1.26B | 1.91B | 137.00M | 2.07B | -1.39B | 909.00M | 844.00M | 1.41B | 4.00B | 1.12B | 934.00M | 1.01B | 867.00M | 615.00M | 776.00M | 1.25B | 560.03M | 1.82B | 579.01M | 580.96M | 799.56M |
Net Income Ratio | 39.67% | 28.47% | -8.71% | 28.29% | 36.73% | 71.79% | 12.31% | 27.74% | 10.28% | 15.14% | 1.08% | 15.59% | -10.07% | 6.95% | 6.49% | 12.00% | 54.88% | 16.86% | 10.73% | 12.48% | 11.40% | 7.93% | 10.72% | 19.20% | 9.74% | 29.00% | 6.60% | 7.52% | 11.06% |
EPS | 5.81 | 3.90 | -1.12 | 3.41 | 4.33 | 6.14 | 2.22 | 4.73 | 1.83 | 2.70 | 0.18 | 2.86 | -1.91 | 1.25 | 1.15 | 1.93 | 7.13 | 1.98 | 1.62 | 1.76 | 1.53 | 1.04 | 1.36 | 2.24 | 0.98 | 3.39 | 1.04 | 1.08 | 1.53 |
EPS Diluted | 5.80 | 3.89 | -1.12 | 3.40 | 4.32 | 6.13 | 2.22 | 4.72 | 1.83 | 2.69 | 0.18 | 2.85 | -1.91 | 1.23 | 1.15 | 1.92 | 7.08 | 1.98 | 1.62 | 1.76 | 1.53 | 1.04 | 1.36 | 2.24 | 0.98 | 3.39 | 1.04 | 1.08 | 1.53 |
Weighted Avg Shares Out | 463.18M | 483.89M | 493.44M | 496.72M | 500.83M | 643.52M | 629.05M | 654.04M | 683.75M | 707.05M | 724.85M | 724.33M | 729.42M | 728.42M | 726.40M | 674.62M | 560.73M | 564.06M | 573.18M | 572.84M | 559.07M | 563.58M | 550.85M | 546.02M | 444.57M | 535.76M | 501.41M | 524.97M | 514.87M |
Weighted Avg Shares Out (Dil) | 463.97M | 484.93M | 494.50M | 498.03M | 502.52M | 644.13M | 630.30M | 655.47M | 686.26M | 709.71M | 727.26M | 726.05M | 729.42M | 732.04M | 728.97M | 678.42M | 564.35M | 564.06M | 573.18M | 573.95M | 571.49M | 563.58M | 550.85M | 546.02M | 536.67M | 535.76M | 501.41M | 524.97M | 514.87M |
KD vs. TRI: Which Stock Is the Better Value Option?
M&A Watch: 3 Canadian Companies That Should Be on American Firms' Buy Lists
FUTU vs. TRI: Which Stock Should Value Investors Buy Now?
AI set to save professionals 12 hours per week by 2029
Thomson Reuters Second-Quarter 2024 Earnings Announcement and Webcast Scheduled for August 1, 2024
FUTU or TRI: Which Is the Better Value Stock Right Now?
Thomson Reuters Announces Voting Results for Election of Directors
Thomson Reuters: Retain Buy Rating As Organic Growth Outlook Remains Positive
SMGZY or TRI: Which Is the Better Value Stock Right Now?
Dr. Michael Donovan Joins Cellworks to Oversee Personalized Cancer Therapy Biosimulation in New CLIA-Certified Lab
Source: https://incomestatements.info
Category: Stock Reports